Asher Chanan-Khan
Director/Board Member bij CELLECTAR BIOSCIENCES, INC.
Vermogen: - $ op 31-03-2024
Profiel
Asher Alban Chanan-Khan is an Independent Director at Cellectar Biosciences, Inc. and a Director at Starton Therapeutics, Inc. He previously worked as a Director at Mayo Clinic Jacksonville and Jacksonville Zoological Society, Inc. He was also a Professor of Medicine and Oncology at Mayo Clinic College of Medicine & Science from 2011 to 2018.
Dr. Chanan-Khan holds a doctorate degree from New York University and Vagelos College of Physicians & Surgeons, and an undergraduate degree from Allama Iqbal Medical College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-09-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Asher Chanan-Khan
| Bedrijven | Functie | Begin |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Director/Board Member | 24-06-2021 |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Director/Board Member | - |
Eerdere bekende functies van Asher Chanan-Khan
| Bedrijven | Functie | Einde |
|---|---|---|
| Mayo Clinic College of Medicine & Science | Corporate Officer/Principal | 01-01-2018 |
Jacksonville Zoological Society, Inc.
 Jacksonville Zoological Society, Inc. Other Consumer ServicesConsumer Services Jacksonville Zoological Society, Inc. operates as a non-profit organization that engages in the management of a zoo. The company is headquartered in Jacksonville, FL. | Director/Board Member | - |
Mayo Clinic Jacksonville
 Mayo Clinic Jacksonville Hospital/Nursing ManagementHealth Services Mayo Clinic Jacksonville provides health care services. It specializes in transplant program, including bone-marrow, heart-lung, kidney, and pancreas. The company was founded in 1986 and is headquartered in Jacksonville, FL. | Director/Board Member | - |
Opleiding van Asher Chanan-Khan
| New York University | Doctorate Degree |
| Allama Iqbal Medical College | Undergraduate Degree |
| Vagelos College of Physicians & Surgeons | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Mayo Clinic Jacksonville
Mayo Clinic Jacksonville Hospital/Nursing ManagementHealth Services Mayo Clinic Jacksonville provides health care services. It specializes in transplant program, including bone-marrow, heart-lung, kidney, and pancreas. The company was founded in 1986 and is headquartered in Jacksonville, FL. | Health Services |
Jacksonville Zoological Society, Inc.
Jacksonville Zoological Society, Inc. Other Consumer ServicesConsumer Services Jacksonville Zoological Society, Inc. operates as a non-profit organization that engages in the management of a zoo. The company is headquartered in Jacksonville, FL. | Consumer Services |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
